Mersana Therapeutics Statistics
Total Valuation
MRSN has a market cap or net worth of $136.47 million. The enterprise value is $82.37 million.
Important Dates
The last earnings date was Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MRSN has 5.00 million shares outstanding. The number of shares has increased by 2.11% in one year.
| Current Share Class | 5.00M |
| Shares Outstanding | 5.00M |
| Shares Change (YoY) | +2.11% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 2.06% |
| Owned by Institutions (%) | 38.64% |
| Float | 3.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.09 |
| Forward PS | 10.36 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.39
| Current Ratio | 1.39 |
| Quick Ratio | 1.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -36.27% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -346.99% |
| Revenue Per Employee | $325,294 |
| Profits Per Employee | -$687,069 |
| Employee Count | 102 |
| Asset Turnover | 0.29 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.81% in the last 52 weeks. The beta is 0.62, so MRSN's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -50.81% |
| 50-Day Moving Average | 11.36 |
| 200-Day Moving Average | 9.83 |
| Relative Strength Index (RSI) | 86.34 |
| Average Volume (20 Days) | 230,544 |
Short Selling Information
The latest short interest is 323,501, so 6.47% of the outstanding shares have been sold short.
| Short Interest | 323,501 |
| Short Previous Month | 303,686 |
| Short % of Shares Out | 6.47% |
| Short % of Float | 8.53% |
| Short Ratio (days to cover) | 5.09 |
Income Statement
In the last 12 months, MRSN had revenue of $33.18 million and -$70.08 million in losses. Loss per share was -$14.09.
| Revenue | 33.18M |
| Gross Profit | -35.85M |
| Operating Income | -67.38M |
| Pretax Income | -70.08M |
| Net Income | -70.08M |
| EBITDA | -66.29M |
| EBIT | -67.38M |
| Loss Per Share | -$14.09 |
Full Income StatementBalance Sheet
The company has $56.39 million in cash and $2.29 million in debt, giving a net cash position of $54.10 million or $10.82 per share.
| Cash & Cash Equivalents | 56.39M |
| Total Debt | 2.29M |
| Net Cash | 54.10M |
| Net Cash Per Share | $10.82 |
| Equity (Book Value) | -59.54M |
| Book Value Per Share | -11.91 |
| Working Capital | 16.72M |
Full Balance SheetCash Flow
| Operating Cash Flow | -74.37M |
| Capital Expenditures | n/a |
| Free Cash Flow | -74.37M |
| FCF Per Share | -$14.88 |
Full Cash Flow StatementMargins
Gross margin is -108.04%, with operating and profit margins of -203.06% and -211.21%.
| Gross Margin | -108.04% |
| Operating Margin | -203.06% |
| Pretax Margin | -211.21% |
| Profit Margin | -211.21% |
| EBITDA Margin | -199.79% |
| EBIT Margin | -203.06% |
| FCF Margin | n/a |
Dividends & Yields
MRSN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.11% |
| Shareholder Yield | -2.11% |
| Earnings Yield | -51.35% |
| FCF Yield | -54.50% |
Analyst Forecast
The average price target for MRSN is $30.38, which is 11.28% higher than the current price. The consensus rating is "Buy".
| Price Target | $30.38 |
| Price Target Difference | 11.28% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 26.12% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 28, 2025. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jul 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
MRSN has an Altman Z-Score of -23.44 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -23.44 |
| Piotroski F-Score | 1 |
